Solar-Tectic Unveils Details of Breakthrough Solar Cell Technology at Energy Conference in Scotland

Solar-Tectic LLC ("ST") presented a paper today at the "Fifth International Symposium on Energy Challenges and Mechanics (ECM5) - working on small scales" in Inverness, Scotland, making public for the first time details of its breakthrough technology for highly efficient and inexpensive solar cells. The paper, titled "High efficiency perovskite/crystalline silicon thin-film tandem solar cell from a highly textured MgO[111] buffered glass substrate: a proposal" has been submitted for publication in the peer reviewed "Journal of Energy Challenges and Mechanics".

Recently perovskite materials have gained much attention as a solution to the longstanding problem of solar cell efficiency, and while there have been many reports of perovskite/silicon tandem solar cells, remarkably there have been none on perovskite/thin-film silicon. Crystalline thin-film silicon promises to be less expensive than silicon wafer technology due to low temperature processing and less material use.

Importantly, the entire process is non-toxic since tin (Sn) is used in the perovskite material, rather than lead (Pb). The technology is the very first of its kind to be published and patents have been filed for world-wide protection.

In May, 2016 Solar-Tectic LLC was granted a patent for a related technology, a hybrid inorganic/polymer thin-film solar cell (see US patent 9.349,995 B2 for details).

For general inquiries or for licensing of ST technologies, please contact Carter Ledyard & Milburn LLP ([email protected], 212-238-8850 FREE).

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.